ArticleJournal of pharmacy & bioallied sciences2024
Association of Serum Albumin and C-Reactive Protein with Outcomes in ESRD Patients Undergoing Hemodialysis at a Tertiary Care Center in Salem, Tamil Nadu.
Article in Journal of pharmacy & bioallied sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- SGA-determined nutritional status predicts cardiac index and protein-energy wasting in peritoneal dialysis patients with end-stage renal disease.Renal failure · 2025Article
- Prediction of Mortality in Hemodialysis Patients Using Inflammation- and Nutrition-Based Indices.Journal of personalized medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic kidney disease (CKD) is a chronic condition characterized by irreversible renal dysfunction, leading to excretory and metabolic failure. Patients with end-stage renal disease (ESRD) often have elevated CRP and reduced albumin levels, causing inflammation. This study compares serum CRP, albumin, urea, creatinine, eGFR, blood pressure, and weight in patients on MHD with ESRD. Methodology: The study measured weight, eGFR, systolic and diastolic blood pressure, serum CRP, albumin, urea, and creatinine in 90 MHD patients and 90 controls using various methods, including GLDH, Jaffe's, BCG, and Nephelometry. Results: The CRP levels in pre hemodialysis were 4.74 ± 2.25 mg/dl and the control group had 0.6 ± 0.2 mg/dl. So comparison of both CRP and albumin in cases and control were highly significant. The pre hemodialysis albumin was 2.74 ± 0.7 mg/dl and control were measured as 4.2 ± 0.5 mg/dl which is statistically significant. The Urea levels in pre hemodialysis were 112.2 ± 23.7 mg/dl and the control group had 24.9 ± 6.2 mg/dl. The Creatinine levels in pre hemodialysis were 8.5 ± 2.7 mg/dl and the control group had 0.8 ± 0.1 mg/dl. The Systolic Blood Pressure (SBP) in pre hemodialysis were 167.0 ± 21.4 mm of Hg and the control group had 121.9 ± 6.9 mm of Hg. The Diastolic Blood Pressure (DBP) in pre hemodialysis were 88.8 ± 10.7 mm of Hg and the control group had 76.8 ± 4.6 mm of Hg. The eGFR in pre hemodialysis was 7.3 ± 4.1 mL/min/1.73 m Conclusion: The study found that patients with MHD had significantly higher CRP, albumin, Urea, Creatinine, SBP, and DBP levels compared to controls, with decreased albumin levels and increased CRP in ESRD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.